Which virus is NOT associated with human cancer?

Oncogenic viruses possess the capability to integrate into the host genome or induce chronic inflammation, leading to malignant cellular transformation. These viruses contribute to approximately 15% of human cancers worldwide. Mechanisms involve the inactivation of tumor suppressor proteins or the activation of viral oncogenes. Hepatitis viruses vary significantly in their oncogenic potential and transmission routes. Rationale: A. HPV (Human Papillomavirus) is a well-established DNA virus associated with several human malignancies, most notably cervical, anal, and oropharyngeal carcinomas. High-risk strains like 16 and 18 produce E6 and E7 oncoproteins. These proteins degrade p53 and pRb, leading to uncontrolled cell cycle progression and eventual tumor development in epithelial tissues. B. HAV (Hepatitis A Virus) is an RNA virus transmitted primarily through the fecal-oral route and causes acute, self-limiting hepatitis. Unlike HBV or HCV, it does not establish chronic infections or integrate into the host's genetic material. Consequently, there is no clinical or epidemiological evidence linking HAV to the development of hepatocellular carcinoma or other cancers. C. HBV (Hepatitis B Virus) is a partially double-stranded DNA virus that is a major cause of chronic liver disease and hepatocellular carcinoma. It can integrate its DNA into the host genome, causing genomic instability and insertional mutagenesis. Chronic inflammation and the production of the HBx protein further drive the oncogenic process in hepatic cells. D. HCV (Hepatitis C Virus) is a single-stranded RNA virus that causes chronic hepatitis, cirrhosis, and liver cancer. Although it does not integrate into the genome, it induces malignancy through persistent oxidative stress and chronic immune-mediated inflammation. The continuous cycle of cell death and regeneration in the liver significantly increases the risk of malignant mutations.